This study aims to evaluate the ability of G8, CARG, and Frailty scales to predict chemotherapy-related toxicity and the need for G-CSF in elderly cancer patients. It also investigates their correlation with nutritional biomarkers (albumin, prealbumin, hemoglobin, CRP) and the Mini Nutritional Assessment (MNA) test.
Eligibility
Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age ≥ 65 years
* Diagnosed with solid tumor malignancy
* Planned to undergo at least two cycles of adjuvant, neoadjuvant, or metastatic chemotherapy
* Clinically stable condition
* Provided written informed consent
Exclusion Criteria:
* Presence of hematological malignancies
* Concurrent hormonal therapy, targeted therapy, immunotherapy, or radiotherapy
* Acute infection or advanced organ failure (cardiac, hepatic, renal)
* Cognitive or psychiatric impairment preventing test participation
* Prior treatment with G-CSF
Primary outcome measure(s)
Side effects of chemotherapy — From enrollment to 6 month
Trial sites (1)
Facility
City
Region
Status
Çanakkale Onsekiz Mart Univercity
Çanakkale
Turkey (Türkiye)
More Çanakkale Onsekiz Mart University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.